Suchergebnisse - "Barlesi, F"

PubPharm (258)

61

Évaluation de l’interaction entre immunothérapie et radiothérapie dans le cancer bronchique non à petites cellules

enthalten in: Revue des maladies respiratoires | 2017

von Chaléat, S. | Grangeon, M. | Pignon, J. | +8

62

Mutations de KRAS : un mécanisme de résistance commun aux traitements bioguidés

enthalten in: Revue des maladies respiratoires | 2017

von Berthelot, A. | Tomasini, P. | Fournier, C. | +3

63

Les essais cliniques de phase précoce peuvent-ils prévoir le profil de tolérance des anticancéreux ciblés ?

enthalten in: Revue des maladies respiratoires | 2017

von Primas, N. | Abcaya, J. | Mascaux, C. | +1

64

142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)

enthalten in: Lung cancer | 2017

von Faivre-Finn, C. | Snee, M. | Ashcroft, L. | +17

65

Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients

enthalten in: The British journal of cancer | 2017

von Faivre, C. | El Cheikh, R. | Barbolosi, D. | +1

66

Efficacy, safety and predictive biomarker results from OAK, a randomized phase III study comparing atezolizumab with docetaxel in patients with advanced NSCLC

enthalten in: Pneumologie | 2017

von Schütte, W. | Barlesi, F. | Park, K. | +17

67

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

enthalten in: Annals of oncology | 2017

von Besse, B. | Mazières, J. | Ribassin-Majed, L. | +18

68

Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma

enthalten in: Revue des maladies respiratoires | 2016

von Fournier, C. | Greillier, L. | Fina, F. | +7

69

Metastatic non-small-cell lung cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Novello, S. | Barlesi, F. | Califano, R. | +11

70

Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs : results from the European EUHER2 cohort

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Mazières, J. | Barlesi, F. | Filleron, T. | +16